CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. TEXT OMITTED FROM THIS EXHIBIT IS MARKED WITH [***]License Modification Agreement • November 25th, 2020 • NTN Buzztime Inc • Pharmaceutical preparations • Florida
Contract Type FiledNovember 25th, 2020 Company Industry JurisdictionAMENDMENT NO. 1 (“Amendment”) dated as of October 30, 2001 to the LICENSE MODIFICATION AGREEMENT (the “Agreement”) by and between University of South Florida Research Foundation, Inc. (“USFRF”) and Immuno-Rx, Inc., a Delaware corporation (the “Company”).